Literature DB >> 6433938

Decreased pokeweed mitogen-induced IgM and IgM rheumatoid factor synthesis in rheumatoid arthritis patients treated with gold sodium thiomalate or penicillamine.

N J Olsen, H E Jasin.   

Abstract

Prospective and retrospective analysis of data obtained on 119 patients with rheumatoid arthritis suggested a relationship between clinical response induced by gold salts or D-penicillamine and decreased in vitro antibody synthesis by peripheral blood mononuclear cells. A subgroup of 21 patients with inactive disease receiving these drugs was found to have decreased pokeweed mitogen-induced in vitro synthesis of IgM and IgM rheumatoid factor. Detailed analysis of the cellular mechanisms responsible for this decreased responsiveness demonstrated markedly decreased B cell function. Patients treated with D-penicillamine also had altered T cell helper function manifested by incomplete reconstitution of the normal IgM response, while patients treated with gold salts had normal T cell function. Monocytes appeared not to have a major role in the decreased in vitro responsiveness. The results suggest that, in patients who respond to gold salts or D-penicillamine, antibody synthesis by circulating B cells is profoundly decreased, probably due to an indirect effect of these disease-modifying agents.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6433938     DOI: 10.1002/art.1780270904

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

1.  Effect of gold therapy on CD5+ B-cells and TCR gamma delta+ T-cells in patients with rheumatoid arthritis.

Authors:  J Hassan; C Feighery; B Bresnihan; A Whelan
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

2.  Evidence for oligoclonal B cell expansion in the peripheral blood of patients with rheumatoid arthritis.

Authors:  D A Fox; B R Smith
Journal:  Ann Rheum Dis       Date:  1986-12       Impact factor: 19.103

3.  Expression of CD 21, CD 22, and the mouse erythrocyte receptor on peripheral B lymphocytes in rheumatoid arthritis.

Authors:  S Hildebrandt; I von der Heydt; P von Wichert
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

4.  The immunological consequences of gold therapy: a prospective study in patients with rheumatoid arthritis.

Authors:  J Hassan; J Hanly; B Bresnihan; C Feighery; C A Whelan
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

5.  Effects of D-penicillamine on mononuclear cells in vitro.

Authors:  J L Riestra; M Harth; A Rodriguez; C L Larrea
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

6.  Proteoglycan biosynthesis by rabbit articular chondrocytes treated with D-penicillamine.

Authors:  P Legendre; M Bouakka; M Langris; J P Pujol; R Beliard; G Loyau; J Bocquet
Journal:  Agents Actions       Date:  1988-08

7.  Correlative studies of rheumatoid factors and anti-viral antibodies in patients with rheumatoid arthritis.

Authors:  A S Ferraro; M M Newkirk
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

8.  Second-line drug treatment in rheumatoid arthritis associated with depressed autologous mixed lymphocyte reaction.

Authors:  G S Panayi; M M Mills
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.